Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPAY
901
DELISTED
Bottomline Technologies Inc
EPAY
| $11.4M | 0.02% |
382,942
-8,921
| -2% | -$252K |
|
902
Thor Industries
THO
$4.11B
| $11.4M | 0.02% |
202,700
+21,659
| +12% | +$1.2M |
|
|
FBC
903
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $11.4M | 0.02% |
491,177
+242,865
| +98% | +$5.58M |
|
904
AXIS Capital
AXS
$7.26B
| $11.3M | 0.02% |
201,500
-97,300
| -33% | -$5.37M |
|
|
DATA
905
DELISTED
Tableau Software, Inc.
DATA
| $11.3M | 0.02% |
120,100
-430,900
| -78% | -$38.7M |
|
|
EVHC
906
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $11.3M | 0.02% |
145,490
+78,356
| +117% | +$6.77M |
|
907
Pricesmart
PSMT
$5.49B
| $11.3M | 0.02% |
136,200
+11,366
| +9% | +$987K |
|
|
NPTN
908
DELISTED
NEOPHOTONICS CORP
NPTN
| $11.3M | 0.02% |
1,040,787
+206,687
| +25% | +$1.87M |
|
909
Bio-Rad Laboratories Class A
BIO
$9.68B
| $11.3M | 0.02% |
81,500
-8,020
| -9% | -$1.11M |
|
|
UTIW
910
DELISTED
UTI WORLDWIDE INC
UTIW
| $11.3M | 0.02% |
1,607,100
+945,779
| +143% | +$6.42M |
|
|
BKMU
911
DELISTED
Bank Mutual Corp
BKMU
| $11.3M | 0.02% |
1,448,233
+37,080
| +3% | +$279K |
|
912
Entravision Communication
EVC
$832M
| $11.3M | 0.02% |
1,461,752
-10,300
| -0.7% | -$83.7K |
|
913
Brunswick
BC
$5.21B
| $11.3M | 0.02% |
+222,800
| New | +$11.5M |
|
|
MKTO
914
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $11.2M | 0.02% |
391,400
+145,100
| +59% | +$4.3M |
|
915
CVR Energy
CVI
$3.52B
| $11.2M | 0.02% |
285,000
+222,000
| +352% | +$9.57M |
|
916
Hubbell
HUBB
$27.1B
| $11.1M | 0.02% |
+110,300
| New | +$11.3M |
|
917
Edison International
EIX
$26.7B
| $11.1M | 0.02% |
188,000
+84,300
| +81% | +$5.15M |
|
|
SJR
918
DELISTED
Shaw Communications Inc.
SJR
| $11.1M | 0.02% |
647,400
-269,038
| -29% | -$5.33M |
|
919
Sturm, Ruger & Co
RGR
$600M
| $11.1M | 0.02% |
186,600
+139,200
| +294% | +$7.82M |
|
920
Moog Inc Class A
MOG.A
$13.6B
| $11.1M | 0.02% |
182,500
-47,117
| -21% | -$2.92M |
|
921
Park Aerospace
PKE
$828M
| $11.1M | 0.02% |
733,900
+43,400
| +6% | +$727K |
|
|
PFC
922
DELISTED
Premier Financial Corp. Common Stock
PFC
| $11M | 0.02% |
584,402
+41,002
| +8% | +$801K |
|
|
SMI
923
DELISTED
Semiconductor Manufacturing Intl
SMI
| $11M | 0.02% |
2,180,090
+85,790
| +4% | +$428K |
|
924
Steris
STE
$23.1B
| $11M | 0.02% |
146,100
-98,500
| -40% | -$7.12M |
|
|
CBL
925
DELISTED
CBL& Associates Properties, Inc.
CBL
| $11M | 0.02% |
887,917
-69,100
| -7% | -$943K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.